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Summary A 76-year-old woman with a diagnosis of dilated-phase hypertrophic cardiomyopa-
thy was admitted to our hospital for exacerbation of congestive heart failure. After admission,
she developed cardiac arrest and the electrocardiogram showed pulseless electrical activ-
ity. Cardiopulmonary resuscitation was started immediately; however, return of spontaneous
circulation was achieved 56min after cardiopulmonary arrest. Therapeutic hypothermia was
considered as an adjunct therapy, together with intensive treatment. The target temperature
of 33.0 ◦C was achieved 10 h after cardiopulmonary arrest. Core temperature was maintained
between 33.0 and 35.0 ◦C for 72 h with no cardiac arrhythmia detected during this period. Re-
warming was initiated at a rate of 1 ◦C/day. On day 6, the core temperature returned to 37 ◦Cspontaneous
circulation
and recovery of consciousness was achieved on day 9. No impairment of neurological function
was noted. She had no heart failure-related symptoms and B-type natriuretic peptide level
decreased from 4174 pg/mL on admission to 450 pg/mL at discharge. Therapeutic hypothermia
may be a promising post-resuscitation therapy for comatose survivors of in-hospital cardiac
arrest with non-ventricular ﬁbri
© 2009 Japanese College of Car
∗ Corresponding author at: Department of Cardiovascular
Medicine, Graduate School of Medical Sciences, Kumamoto Univer-
sity, 1-1-1 Honjo, Kumamoto City 860-8556, Japan.
Tel.: +81 96 373 5175; fax: +81 96 362 3256.
E-mail address: kojimas@kumamoto-u.ac.jp (S. Kojima).
I
R
o
r
o
1878-5409/$ — see front matter © 2009 Japanese College of Cardiology.
doi:10.1016/j.jccase.2009.07.001llation leading to improvement in neurological outcome.
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ntroductionecent reports have demonstrated that paramedics carry
ut electrical cardioversion by automated external deﬁb-
illator and that successful deﬁbrillation can be achieved
utside the hospital [1]. The 2005 American Heart
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(Figure 1 Electrocardio
ssociation Guidelines for Cardiopulmonary Resuscitation
nd Emergency Cardiovascular Care recommend mild thera-
eutic hypothermia for patients with return of spontaneous
irculation (ROSC) after out-of-hospital cardiac arrest [2].
owever, the initial cardiac rhythm of comatose patients is
imited to ventricular ﬁbrillation (VF).
We present a patient who developed in-hospital cardiac
rrest with non-VF rhythm and achieved ROSC after 1-h
tandard cardiopulmonary resuscitation (CPR). Therapeutic
ypothermia over 6 days, in combination with a series of
herapeutic interventions, resulted in full recovery without
ny neurological deﬁcits.
ase report76-year-old woman was diagnosed with hypertrophic
ardiomyopathy and atrial ﬁbrillation 14 years prior to
he present admission. Her mother and elder sister were
lso known to have hypertrophic cardiomyopathy. She was
reated chieﬂy with diuretics and warfarin in the outpatient
b
s
e
D
hon hospital admission.
linic. Transthoracic echocardiogram showed low left ven-
ricular (LV) ejection fraction, LV dilatation, and progressive
V wall thinning in recent years. Based on these ﬁndings, the
isease stage was considered the dilated phase of hyper-
rophic cardiomyopathy.
She developed dyspnea associated with congestive heart
ailure and was treated by intravenous diuretics by the
amily physician. However, urinary output was limited and
ystolic blood pressure was 70mmHg. The symptoms of
eart failure deteriorated and she was transferred to the
mergency room in our hospital by an ambulance. On
dmission, blood pressure was 100/70mmHg and heart rate
as 60 beats/min under infusion of dopamine 3. Arte-
ial oxygen saturation was 90% during oxygen breathing at
L/min through a nasal cannula. The electrocardiogram
ECG) showed sinus rhythm with complete right bundle
ranch block (Fig. 1) and transthoracic echocardiogram
howed LV dilatation and severe diffuse hypokinesis (LV
nd-diastolic diameter: 69mm; LV ejection fraction: 20%).
uring clinical examination, she developed rapid fall in
eart rate and hypotension, with imminent cardiogenic
Therapeutic hypothermia in a patient with in-hospital cardiac ar
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gFigure 2 Chest X-ray on hospital admission.
shock and she was quickly taken to the cardiac catheteriza-
tion room. Within minutes, she developed cardiopulmonary
arrest and the ECG monitor showed pulseless electrical
activity (PEA). According to the protocol of advanced cardio-
vascular life support, CPR was started immediately together
with tracheal intubation, but spontaneous circulation did
not resume immediately. ROSC was achieved exactly 56min
after cardiopulmonary arrest, during which a temporary pac-
ing lead, an aortic balloon for intra-aortic balloon pumping,
and a central venous catheter were inserted. The patient
was subsequently transferred to the intensive care unit (ICU)
for close monitoring and treatment.
In the ICU, the Glasgow Coma Scale was E1V1M1. Both
pupils were dilated (∅ 5mm) and the light reﬂex was absent.
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Figure 3 Clinical course. CHDF, continuous hemodiaﬁltration; DOA
rial pressure; hANP, human atrial natriuretic peptide; IABP, intra-aor
LVEF, left ventricular ejection fraction; NA, noradrenaline; d/sPAP, drest e47
ody temperature was 36.2 ◦C as measured by a probe
nserted into the bladder. A plain chest X-ray showed car-
iomegaly and pulmonary congestion (Fig. 2). The laboratory
ests were performed. Serum creatinine (1.81mg/dL) and
reatine phosphokinase levels (1113U/L) were increased
nd the level of B-type natriuretic peptide (BNP) was
174 pg/mL; however, serum troponin T level was normal
0.03 ng/mL).
Therapeutic hypothermia was considered as a curative
ption for this patient (Fig. 3). Mild to moderate hypother-
ia was maintained with a water blanket and was combined
ith continuous hemodiaﬁltration to treat the associated
cute renal failure. The patient was sedated with propo-
ol and fentanyl, and treated with vecuronium bromide to
revent shivering. The target body temperature of 33.0 ◦C
as achieved 10 h after cardiopulmonary arrest. The core
emperature was maintained between 33.0 and 35.0 ◦C for
2 h and no arrhythmia was detected during this period.
e-warming was initiated at a rate of 1 ◦C/day. During
he re-warming phase, atrial ﬁbrillation with tachycardia
ften occurred, necessitating intravenous infusion of pro-
ainamide as well as cardioversion.
On day 6, the core temperature returned to 37 ◦C, thus
nding the period of therapeutic hypothermia. At that stage,
he intra-aortic balloon pump was removed and the doses
f inotropic agents were increased on day 7. On day 8,
nfusion of the sedative drug was discontinued, the patient
as extubated, and she ﬁnally regained consciousness (Glas-
ow come scale: E3V5M6) on day 9. On day 12, infusion
f inotropic agents was gradually decreased and treat-
ent with oral angiotensin-converting enzyme inhibitor,
-blocker, and amiodarone was initiated. At that stage,
etailed neurological examination showed no functional
eﬁcits. She had no heart failure-related symptoms and the
, dopamine; DOB, dobutamine; dPAP, diastolic pulmonary arte-
tic balloon pumping; LVDd, left ventricular diastolic diameter;
iastolic/systolic pulmonary arterial pressure.
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NP level decreased to 450 pg/mL on hospital discharge.
he LV end-diastolic dimension at discharge (69mm) was
omparable to that on admission, however LV ejection frac-
ion increased from 20% on admission to 44% at discharge.
close follow-up at the outpatient clinic over the 2 years
fter discharge showed no recurrence of heart failure.
iscussion
herapeutic hypothermia is recommended for patients with
OSC after out-of-hospital cardiac arrest due to VF and has
een reported to improve survival and neurological function
2,3]. One study documented improved metabolic endpoints
lactate and O2 extraction) when comatose patients were
ooled after ROSC from out-of-hospital cardiac arrest in
hich the initial rhythm was PEA/asystole [4]. A small
tudy also reported beneﬁts after therapeutic hypothermia
n comatose survivors of non-VF arrest [5]. On the other
and, few studies have reported the beneﬁts for patients
ith in-hospital cardiac arrest. The largest published in-
ospital cardiac arrest database by the National Registry of
ardiopulmonary Resuscitation Investigators indicates that
ulseless arrest rhythm in adults is typically PEA/asystole
ssociated with preexisting conditions, such as progressive
espiratory failure, circulatory shock, or both, compared
ith VF or pulseless ventricular tachycardia [6]. Further-
ore, the reported survival rate to hospital discharge
ollowing PEA/asystole is only 11% [6].
The ultimate goal of resuscitation in patients with in-
ospital cardiac arrest is survival to hospital discharge with
ood neurological outcome. Interventions likely to improve
urvival include early recognition, faster and better resus-
itation, and stabilization of such patients. The present
ase developed PEA associated with congestive heart fail-
re and deterioration of LV function. About 1 h passed until
he achievement of ROSC although CPR was initiated imme-
iately after cardiac arrest. The reason for the effectiveness
f therapeutic hypothermia in this case could not be eluci-
ated. It is questionable whether therapeutic hypothermia
s suitable for patients having severe cardiac dysfunction
ecause drastic changes of body temperature may cause
rrhythmia, leading to hemodynamic deterioration. There-
ore, a gentle protocol on temperature regulation was
dopted. Actually, atrial ﬁbrillation with tachycardia often
ccurred during the re-warming phase and we had trou-
le ceasing a surge of arrhythmia in this case. This caseY. Arima et al.
ay be appropriate for percutaneous cardiopulmonary sup-
ort (PCPS), but she was a person of advanced age and her
emodynamics could be supported by intra-aortic balloon
umping alone after successful resuscitation. The PCPS has
ot been managed in the clinical course although we thought
bout the use of PCPS in this case. However, we actively
nduced therapeutic hypothermia in addition to mechanical
upport and aggressive treatment in the hope of improve-
ent of survival and preservation of neurological function.
The indication of therapeutic hypothermia is limited
ccording to the 2005 American Heart Association Guidelines
or Cardiopulmonary Resuscitation and Emergency Cardio-
ascular Care [2]. Further evaluation in a large number
f patients is required to conﬁrm the beneﬁcial effects of
ypothermia in patients who develop in-hospital cardiac
rrest with non-VF rhythms and have preexisting severe
onditions. Therapeutic hypothermia may be a promising
ost-resuscitation therapy for comatose survivors of in-
ospital cardiac arrest, leading to improvement of survival
ith minimal or no neurological deﬁcits.
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